Genmab A/S (OTCMKTS:GNMSF – Get Free Report) released its quarterly earnings results on Thursday. The company reported $5.42 EPS for the quarter, beating analysts’ consensus estimates of $3.56 by $1.86, Zacks reports. Genmab A/S Stock PerformanceShares of OTCMKTS:GNMSF traded up $5.00 during midday trading on Thursday, reaching $295.00. The company had a trading volume of 248 shares, compared to its average volume of 2,014. Featured ArticlesReceive News & Ratings for Genmab A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genmab A/S and related companies with MarketBeat.com's FREE daily email newsletter.